{"id":"NCT02066636","sponsor":"Bristol-Myers Squibb","briefTitle":"A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen","officialTitle":"A Phase IIIb/IV Safety Trial of Nivolumab (BMS-936558) in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Systemic Regimen","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-04-09","primaryCompletion":"2021-10-06","completion":"2021-10-06","firstPosted":"2014-02-19","resultsPosted":"2022-10-27","lastUpdate":"2022-10-27"},"enrollment":1428,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Non Small Cell Lung Cancer (NSCLC)"],"interventions":[{"type":"DRUG","name":"Nivolumab","otherNames":["BMS-936558"]}],"arms":[{"label":"Cohort A: Nivolumab","type":"EXPERIMENTAL"},{"label":"Cohort B: Nivolumab","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to estimate the incidence and characterize the outcome of high grade, select adverse events in subjects with advanced or metastatic NSCLC treated with Nivolumab.","primaryOutcome":{"measure":"The Number of Participants With Treatment Related Select Adverse Events (Grade 3-4 and Grade 5)","timeFrame":"From first dose and 100 days after last dose (last dose up to randomization for cohort B) (up to approximately 88 months)","effectByArm":[{"arm":"Cohort A: Nivolumab Monotherapy (Post-Randomization)","deltaMin":3,"sd":null},{"arm":"Cohort B: Nivolumab Monotherapy (Post-Randomization)","deltaMin":0,"sd":null},{"arm":"Nivolumab Monotherapy (Pre-Randomized)","deltaMin":20,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":12,"exclusionCount":null},"locations":{"siteCount":134,"countries":["United States","Canada"]},"refs":{"pmids":["31121324"],"seeAlso":["https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html","http://www.BMSStudyConnect.com"]},"adverseEventsSummary":{"seriousAny":{"events":57,"n":127},"commonTop":["Fatigue","Dyspnoea","Nausea","Cough","Decreased appetite"]}}